(Q30203302)

10 June 2017

1 reference

title

The avian influenza vaccine Emerflu. Why did it fail? (English)

1 reference

10 June 2017

1 reference

1 reference

Sapna P Sadarangani

2

0 references

Barnaby Young

object named as

Barnaby E Young

series ordinal

1

0 references

Yee-Sin Leo

series ordinal

3

object named as

Yee Sin Leo

1 reference

10 June 2017

publication date

22 June 2015

1 reference

Expert Review of Vaccines

10 June 2017

published in

1 reference

10 June 2017

volume

14

1 reference

10 June 2017

issue

8

1 reference

10 June 2017

page(s)

1125-1134

1 reference

An overview of the epidemiology of avian influenza

10 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

New world bats harbor diverse influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Is low pathogenic avian influenza virus virulent for wild waterbirds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

History of highly pathogenic avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Natural history of highly pathogenic avian influenza H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Airborne transmission of influenza A/H5N1 virus between ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

A synchronized global sweep of the internal genes of modern avian influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Pandemic H5N1 influenza vaccine development: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Vaccine adjuvant safety: the elephant in the room

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Selection of influenza vaccine strains and developing pandemic vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Adjuvants in influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Novel role of PKR in inflammasome activation and HMGB1 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Enhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

A novel influenza A (H1N1) vaccine in various age groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Working together: interactions between vaccine antigens and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Alum adjuvant: some of the tricks of the oldest adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Immune response to vaccine adjuvants during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Immunological assessment of influenza vaccines and immune correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

21 January 2018

H5N1 vaccines in humans

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

The vaccination coverage required to establish herd immunity against influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

H5N1 vaccines: how prepared are we for a pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.1059760

10.1586/14760584.2015.1059760

21 January 2018

Identifiers

DOI

1 reference

10 June 2017

1 reference